Similar articles

• Vaccines based on recombinant antigen strategies.

  Minor P. Minor P. Dev Biol (Basel). 2001;105:189-94. Dev Biol (Basel). 2001. PMID: 11763327 Review. No abstract available.
• [Variability of poliomyelitis virus strains in nature and significance of this factor for the prevention of poliomyelitis].

  Gendon IuZ. Gendon IuZ. Vopr Virusol. 1988 Mar-Apr;33(2):137-41. Vopr Virusol. 1988. PMID: 2457986 Review. Russian. No abstract available.
• Isolation of an intertypic poliovirus capsid recombinant from a child with vaccine-associated paralytic poliomyelitis.

  Martín J, Samoilovich E, Dunn G, Lackenby A, Feldman E, Heath A, Svirchevskaya E, Cooper G, Yermalovich M, Minor PD. Martín J, et al. J Virol. 2002 Nov;76(21):10921-8. doi: 10.1128/jvi.76.21.10921-10928.2002. J Virol. 2002. PMID: 12368335 Free PMC article.
• Poliovirus vaccines.

  Racaniello VR. Racaniello VR. Biotechnology. 1992;20:205-22. doi: 10.1016/b978-0-7506-9265-6.50015-4. Biotechnology. 1992. PMID: 1318134 Review. No abstract available.
• Inactivated poliovirus vaccine and vaccine-associated paralytic poliomyelitis.

  Brown B. Brown B. JAMA. 1997 Jan 22-29;277(4):295. JAMA. 1997. PMID: 9002483 No abstract available.